WINNIPEG, Manitoba - (June 21, 2004) - Medicure
Inc. (TSX:MPH/Amex:MCU), a cardiovascular drug discovery and development
company, is pleased to announce that it has been accepted to present
at the American Stock Exchange's Annual Amex IR Alliance Online
Healthcare and Biotech Investor Conference.
The Medicure presentation will be given by Dawson J. Reimer, Vice-President,
Operations, and will take place at 1:30 pm (Eastern Time) on Tuesday,
June 22, 2004.
"This is another excellent opportunity for Medicure to further
raise its profile with investors across the United States and Canada,"
said Mr. Reimer. "We are pleased to be participating in this
Amex webcast conference, as it supports a growing recognition of
Medicure, its products and management team."
Information on this event is as follows:
What: Medicure Inc. Presentation at the American Stock Exchange
and Amex IR Alliance Online Conference
When: June 22, 2004 at 1:30 PM EDT
Where: http://www.vcall.com/CEPage.asp?ID=88414
How: Live over the Internet --- simply log on to the web address
above
If you are unable to participate during the live webcast, the presentation
will be archived at www.vcallconferences.com.
About Medicure Inc.
Medicure Inc. (TSX:MPH/Amex: MCU) is a cardiovascular drug discovery
and development Company focused on developing effective therapeutics
for unmet needs in the field of cardiovascular medicine. The Company's
lead drug, MC-1, is focused on the prevention and treatment of ischemia,
ischemic reperfusion injury, and stroke. The cardiovascular and
stroke market is the largest pharmaceutical sector with annual global
sales of over US $70 billion.
The Company's second product candidate, MC-4232, is being targeted
for the treatment of hypertension and related, co-existing conditions.
Hypertension is a common disorder in which blood pressure remains
abnormally high. Approximately 73% of the more than 50 million adult
Americans who have hypertension, are not adequately treated.
Medicure also has a medicinal chemistry based Drug Discovery program
focused on discovery and advancement of novel small molecule, anti-ischemics
and anti-thrombotics towards human clinical studies.
About The American Stock Exchange
The American Stock Exchange® (Amex®) is the only primary
exchange that offers trading across a full range of equities, options
and exchange traded funds (ETFs), including structured products
and HOLDRSSM. In addition to its role as a national equities market,
the Amex is the pioneer of the ETF, responsible for bringing the
first domestic product to market in 1993. Leading the industry in
ETF listings, the Amex lists 138 ETFs to date. The Amex is also
one of the largest options exchanges in the U.S., trading options
on broad-based and sector indexes as well as domestic and foreign
stocks.
Minimum requirements to listen to broadcast are as follows:
Windows Media Player software, downloadable free from
http://microsoft.com/windows/windowsmedia/EN/default.asp
and at least a
28.8Kbps connection to the Internet. If you experience problems
listening to the
broadcast, please send an email to webmaster@vcall.com.
For a complete agenda of the American Stock Exchange and Amex IR
Alliance Online Conference, please visit http://www.vcallconferences.com/conferences/AMEX/0622-29-2004/index.asp?ID=88206.
This
news release contains forward-looking statements that involve risks,
which may cause actual results to differ materially from the statements
made, and accordingly may be deemed to be forward-looking statements
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. The forward-looking statements are
made as of the date hereof, and the Company disclaims any intention
and has no obligation or responsibility to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
For more information, please contact:
Derek Reimer
Chief Financial Officer
Don Bain
Director of Investor & Public Relations
